{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:24:17Z","timestamp":1790281457075,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.neulet.2019.134313","type":"journal-article","created":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T01:08:45Z","timestamp":1559437725000},"page":"134313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Meta-analysis of related factors of impulse control disorders in patients with Parkinson's disease"],"prefix":"10.1016","volume":"707","author":[{"given":"Bo","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingmin","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunying","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2019.134313_bib0005","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jns.2016.12.060","article-title":"Neuropsychiatric symptoms, behavioural disorders, and quality of life in Parkinson\u2019s disease","volume":"373","author":"Balestrino","year":"2017","journal-title":"J. Neurol. Sci."},{"issue":"8","key":"10.1016\/j.neulet.2019.134313_bib0010","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.parkreldis.2014.05.014","article-title":"Impulse control and related disorders in Mexican Parkinson\u2019s disease patients","volume":"20","author":"Rodriguez-Violante","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neulet.2019.134313_bib0015","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archneurol.2010.65","article-title":"Impulse control disorders in Parkinsondisease: a cross-sectional study of 3090 patients","volume":"67","author":"Weintraub","year":"2010","journal-title":"Arch. Neurol."},{"issue":"4","key":"10.1016\/j.neulet.2019.134313_bib0020","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1155\/2013\/826742","article-title":"Impulse control disorders in Parkinson\u2019s disease: crossroads between neurology, psychiatry and neuroscience","volume":"27","author":"Bugalho","year":"2013","journal-title":"Behav. Neurol."},{"issue":"4","key":"10.1016\/j.neulet.2019.134313_bib0025","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1586\/14737175.2016.1158103","article-title":"Treatment of impulse control disorders in Parkinson\u2019s disease: practical considerations and future directions","volume":"16","author":"Ramirez-Zamora","year":"2016","journal-title":"Expert Rev. Neurother."},{"issue":"1","key":"10.1016\/j.neulet.2019.134313_bib0030","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3233\/JPD-160977","article-title":"Impulsive and compulsive behaviors in Parkinson\u2019s disease: the norwegian ParkWest study","volume":"7","author":"Erga","year":"2017","journal-title":"J. Parkinsons Dis."},{"issue":"3","key":"10.1016\/j.neulet.2019.134313_bib0035","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1212\/WNL.0000000000005816","article-title":"Longitudinal analysis of impulse control disorders in Parkinson disease","volume":"91","author":"Corvol","year":"2018","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neulet.2019.134313_bib0040","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4103\/0972-2327.144311","article-title":"Impulse control disorders and related behaviours (ICD-RBs) in Parkinson\u2019s disease patients: assessment using \"Questionnaire for impulsive-compulsive disorders in Parkinson\u2019s disease\" (QUIP)","volume":"18","author":"Sharma","year":"2015","journal-title":"Ann. Indian Acad. Neurol."},{"issue":"8","key":"10.1016\/j.neulet.2019.134313_bib0045","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/jnnp-2013-306787","article-title":"Impulse control disorder in patients with Parkinson\u2019s disease under dopamine agonist therapy: a multicentre study","volume":"85","author":"Garcia-Ruiz","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.neulet.2019.134313_bib0050","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/JCP.0b013e3182979830","article-title":"A single-center, cross-sectional prevalence study of impulse control disorders in Parkinson disease: association with dopaminergic drugs","volume":"33","author":"Poletti","year":"2013","journal-title":"J. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.neulet.2019.134313_bib0055","first-page":"196","article-title":"Related factors analysis of impulse control disorders in 112 Parkinson\u2019s disease patients","volume":"12","author":"Li","year":"2014","journal-title":"Chin. J. Integr. Med. Cardio\/Cerebrovasc. Dis."},{"issue":"5","key":"10.1016\/j.neulet.2019.134313_bib0060","first-page":"321","article-title":"Relationship between impulsive control disorders,mood dysfunction and dopamine in patients with Parkinson disease","volume":"27","author":"Wang","year":"2014","journal-title":"J. Clin. Neurol."},{"issue":"3","key":"10.1016\/j.neulet.2019.134313_bib0065","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neulet.2019.134313_bib0070","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/mds.22571","article-title":"Validation of the questionnaire forimpulsive-compulsive disorders in Parkinson\u2019s disease","volume":"24","author":"Weintraub","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neulet.2019.134313_bib0075","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/mds.23429","article-title":"Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease","volume":"25","author":"Tomlinson","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neulet.2019.134313_bib0080","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1471-2288-11-41","article-title":"Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics","volume":"11","author":"Bowden","year":"2011","journal-title":"BMC Med. Res. Methodol."},{"issue":"7414","key":"10.1016\/j.neulet.2019.134313_bib0085","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"7626","key":"10.1016\/j.neulet.2019.134313_bib0090","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/bmj.39343.408449.80","article-title":"Uncertainty in heterogeneity estimates in meta-analyses","volume":"335","author":"Ioannidis","year":"2007","journal-title":"BMJ"},{"issue":"7109","key":"10.1016\/j.neulet.2019.134313_bib0095","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.neulet.2019.134313_bib0100","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/0272-4332.00040","article-title":"Sensitivity analysis for importance assessment","volume":"22","author":"Saltelli","year":"2002","journal-title":"Risk Anal."},{"issue":"4","key":"10.1016\/j.neulet.2019.134313_bib0105","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1136\/jnnp-2016-315277","article-title":"ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson\u2019s disease","volume":"88","author":"Antonini","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.neulet.2019.134313_bib0110","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/ene.12646","article-title":"Impulse control disorders in Parkinson\u2019s disease: don\u2019t set your mind at rest by self-assessments","volume":"22","author":"Baumann-Vogel","year":"2015","journal-title":"Eur. J. Neurol."},{"issue":"7","key":"10.1016\/j.neulet.2019.134313_bib0115","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s10072-012-1224-5","article-title":"Neuropsychological features of patients with Parkinson\u2019s disease and impulse control disorders","volume":"34","author":"Bentivoglio","year":"2013","journal-title":"Neurol. Sci."},{"issue":"11","key":"10.1016\/j.neulet.2019.134313_bib0120","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/mds.27181","article-title":"Impulse control disorders in advanced Parkinson\u2019s disease with dyskinesia: the ALTHEA study","volume":"32","author":"Biundo","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neulet.2019.134313_bib0125","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.pbb.2014.11.017","article-title":"Proficient motor impulse control in Parkinson disease patients with impulsive and compulsive behaviors","volume":"129","author":"Claassen","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.neulet.2019.134313_bib0130","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3233\/JPD-140351","article-title":"Impulse control disorders are associated with multiple psychiatric symptoms in Parkinson\u2019s disease","volume":"4","author":"Jaakkola","year":"2014","journal-title":"J. Parkinsons Dis."},{"issue":"2","key":"10.1016\/j.neulet.2019.134313_bib0135","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00415-012-6645-9","article-title":"Clinical characteristics of impulse control and repetitive behavior disorders in Parkinson\u2019s disease","volume":"260","author":"Kim","year":"2013","journal-title":"J. Neurol."},{"issue":"7","key":"10.1016\/j.neulet.2019.134313_bib0140","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.parkreldis.2013.03.004","article-title":"Past smoking and current dopamine agonist use show an independent and dose-dependent association with impulse control disorders in Parkinson\u2019s disease","volume":"19","author":"Valenca","year":"2013","journal-title":"Parkinsonism Relat. Disord."},{"issue":"6","key":"10.1016\/j.neulet.2019.134313_bib0145","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/ana.22356","article-title":"Impulse control disorders in Parkinson disease: a multicenter case--control study","volume":"69","author":"Voon","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2019.134313_bib0150","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/bs.irn.2017.04.006","article-title":"Impulse control and related disorders in Parkinson\u2019s disease","volume":"133","author":"Weintraub","year":"2017","journal-title":"Int. Rev. Neurobiol."},{"issue":"2","key":"10.1016\/j.neulet.2019.134313_bib0155","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1212\/WNL.0b013e31827b915c","article-title":"Screening for impulse control symptoms in patients with de novo Parkinson disease: a case-control study","volume":"80","author":"Weintraub","year":"2013","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.neulet.2019.134313_bib0160","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1111\/ene.13078","article-title":"Impulse control disorder related behaviours during long-term rotigotine treatment: a post hoc analysis","volume":"23","author":"Antonini","year":"2016","journal-title":"Eur. J. Neurol."},{"issue":"4","key":"10.1016\/j.neulet.2019.134313_bib0165","first-page":"231","article-title":"Clinical and psychopathological factors associated with impulse control disorders in Parkinson\u2019s disease","volume":"31","author":"Saez-Francas","year":"2016","journal-title":"Neurologia"},{"issue":"11","key":"10.1016\/j.neulet.2019.134313_bib0170","doi-asserted-by":"crossref","first-page":"145","DOI":"10.17116\/jnevro2016116111145-156","article-title":"Predictors and modifiers of impulse control disorders in Parkinson`s disease","volume":"116","author":"Sapronova","year":"2016","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"issue":"2","key":"10.1016\/j.neulet.2019.134313_bib0175","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/mds.26016","article-title":"Clinical spectrum of impulse control disorders in Parkinson\u2019s disease","volume":"30","author":"Weintraub","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neulet.2019.134313_bib0180","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/1756285613476127","article-title":"Diagnosis and treatment of impulse control disorders in patients with movement disorders","volume":"6","author":"Mestre","year":"2013","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"5","key":"10.1016\/j.neulet.2019.134313_bib0185","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/mds.26154","article-title":"Patterns of cortical thickness associated with impulse control disorders in Parkinson\u2019s disease","volume":"30","author":"Biundo","year":"2015","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.neulet.2019.134313_bib0190","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mds.26068","article-title":"Linking neuroscience with modern concepts of impulse control disorders in Parkinson\u2019s disease","volume":"30","author":"Napier","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neulet.2019.134313_bib0195","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1001\/archneurol.2011.41","article-title":"Dopamine agonists vs levodopa in impulse control disorders","volume":"68","author":"Grosset","year":"2011","journal-title":"Arch. Neurol."},{"issue":"3","key":"10.1016\/j.neulet.2019.134313_bib0200","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/mds.25291","article-title":"Prospective cohort study of impulse control disorders in Parkinson\u2019s disease","volume":"28","author":"Bastiaens","year":"2013","journal-title":"Mov. Disord."},{"issue":"7","key":"10.1016\/j.neulet.2019.134313_bib0205","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archneur.63.7.969","article-title":"Dopamine agonist use is associated with impulse control disorders in Parkinson\u2019s disease","volume":"63","author":"Weintraub","year":"2006","journal-title":"Arch. Neurol."},{"issue":"7","key":"10.1016\/j.neulet.2019.134313_bib0210","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1212\/01.wnl.0000238503.20816.13","article-title":"Prevalence of repetitive and reward-seeking behaviors in Parkinson disease","volume":"67","author":"Voon","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2019.134313_bib0215","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/ana.22356","article-title":"Impulse control disorders in Parkinson disease: a multicenter case\u2013control study","volume":"69","author":"Voon","year":"2011","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.neulet.2019.134313_bib0220","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.bandc.2009.04.003","article-title":"On the role of dopamine replacement therapy in decisionmaking, working memory, and reward in Parkinson\u2019s disease: does the therapy-dose matter?","volume":"71","author":"Torta","year":"2009","journal-title":"Brain Cogn."},{"key":"10.1016\/j.neulet.2019.134313_bib0225","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/mds.25291","article-title":"Prospective cohort study of impulse control disorders in Parkinson\u2019s disease","volume":"28","author":"Bastiaens","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neulet.2019.134313_bib0230","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1517\/14740338.2012.678830","article-title":"Drug safety evaluation of rotigotine","volume":"11","author":"Sprenger","year":"2012","journal-title":"Expert Opin. Drug Saf."},{"issue":"6","key":"10.1016\/j.neulet.2019.134313_bib0235","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/WNF.0b013e31826e6e6d","article-title":"Prevalence and pharmacological factors associated with impulse-control disorder symptoms in patients with Parkinson disease","volume":"35","author":"Perez-Lloret","year":"2012","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.neulet.2019.134313_bib0240","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.parkreldis.2013.02.007","article-title":"Pathological gambling in Parkinson\u2019s disease. A comprehensive review","volume":"19","author":"Santangelo","year":"2013","journal-title":"Parkinsonism Relat. Disord."},{"issue":"6","key":"10.1016\/j.neulet.2019.134313_bib0245","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.22164","article-title":"Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study","volume":"68","author":"Weintraub","year":"2010","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.neulet.2019.134313_bib0250","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/WCO.0b013e3283489687","article-title":"Impulse control disorders in Parkinson\u2019s disease: recent advances","volume":"24","author":"Voon","year":"2011","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.neulet.2019.134313_bib0255","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.parkreldis.2016.06.005","article-title":"Dopamine D3 receptor Ser9Gly variant is associated with impulse control disorders in Parkinson\u2019s disease patients","volume":"30","author":"Krishnamoorthy","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"issue":"1","key":"10.1016\/j.neulet.2019.134313_bib0260","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/mds.23400","article-title":"Differential genetic susceptibility in diphasic and peak-dose dyskinesias in Parkinson\u2019s disease","volume":"26","author":"Lee","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neulet.2019.134313_bib0265","first-page":"15","article-title":"DRD and GRIN2B polymorphisms and their association with the development of impulse control behaviour among Malaysian Parkinson\u2019s disease patients","author":"Zainal Abidin","year":"2015","journal-title":"BMC Neurol."},{"key":"10.1016\/j.neulet.2019.134313_bib0270","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.parkreldis.2016.05.017","article-title":"Tryptophan hydroxylase type 2 variants modulate severity and outcome of addictive behaviors in Parkinson\u2019s disease","volume":"29","author":"Cilia","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"issue":"10","key":"10.1016\/j.neulet.2019.134313_bib0275","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1136\/jnnp-2015-312848","article-title":"Clinical-genetic model predicts incident impulse control disorders in Parkinson\u2019s disease","volume":"87","author":"Kraemmer","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394019303933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394019303933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T20:27:52Z","timestamp":1759609672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394019303933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":55,"alternative-id":["S0304394019303933"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2019.134313","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meta-analysis of related factors of impulse control disorders in patients with Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2019.134313","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"134313"}}